Correction to the Abstract: Positive Predictive Value Confidence Interval for AI-Assisted Detection of Subclinical Basal Cell Carcinoma
-
October 1, 2026
October 1, 2026
Harold Burstein, MD, PhD, and Adrienne Waks, MD discuss the HER2Climb-05 trial and how it impacts treatment for HER2+ metastatic breast cancer
October 15, 2026